Gestational diabetes mellitus: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data

The Brighton Collaboration Gestational Diabetes Mellitus Working Group

doi:10.1016/j.vaccine.2017.01.043

Gestational diabetes mellitus: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data

The Brighton Collaboration Gestational Diabetes Mellitus Working Group

School of Public Health

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	6555-6562
Number of pages	8
Journal	Vaccine
Volume	35
Issue number	48
DOIs	https://doi.org/10.1016/j.vaccine.2017.01.043
State	Published - Dec 4 2017

ASJC Scopus Subject Areas

Molecular Medicine
General Immunology and Microbiology
General Veterinary
Public Health, Environmental and Occupational Health
Infectious Diseases

Access to Document

10.1016/j.vaccine.2017.01.043License: Unspecified

OpenUrl availability

Full text

Cite this

@article{a952d51525fe426ba13220b5b033f18b,

title = "Gestational diabetes mellitus: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data",

author = "{The Brighton Collaboration Gestational Diabetes Mellitus Working Group} and Alisa Kachikis and Eckert, {Linda O.} and Christie Walker and Eugene Oteng-Ntim and Rama Guggilla and Manish Gupta and Manasi Patwardhan and Ronald Mataya and {Mallett Moore}, Tamala and Alguacil-Ramos, {Ana Maria} and Cheryl Keech and Michael Gravett and Helen Murphy and Sonali Kochhar and Nancy Chescheir",

note = "Funding Information: The authors are grateful for the support and helpful comments provided by the Brighton Collaboration and the reference group (see https://brightoncollaboration.org/public/what-we-do/setting-standards/case-definitions/groups.html for reviewers), as well as other experts consulted as part of the process. These experts include Dr. Alastair McKelvey, Subspecialist in Maternal-Fetal Medicine and Associate Professor in Obstetrics and Gynaecology at the Norfolk and Norwich University Hospitals NHS Foundation Trust, UK, as well as Lara Handler, Medicine Librarian, UNC Health Sciences Library, Monica Weiss-Nolen, Information Scientist at Sanofi Pasteur, USA, and Sonja Banga, at Sanofi Pasteur, Canada. The authors are also grateful to Jan Bonhoeffer, Jorgen Bauwens of the Brighton Collaboration Secretariat and Sonali Kochhar of Global Healthcare Consulting for final revisions of the final document. Finally, we would like to acknowledge the Global Alignment of Immunization Safety Assessment in Pregnancy (GAIA) project, funded by the Bill and Melinda Gates Foundation. ",

year = "2017",

month = dec,

day = "4",

doi = "10.1016/j.vaccine.2017.01.043",

language = "English",

volume = "35",

pages = "6555--6562",

journal = "Vaccine",

issn = "0264-410X",

number = "48",

}

TY - JOUR

T1 - Gestational diabetes mellitus

T2 - Case definition & guidelines for data collection, analysis, and presentation of immunization safety data

AU - The Brighton Collaboration Gestational Diabetes Mellitus Working Group

AU - Kachikis, Alisa

AU - Eckert, Linda O.

AU - Walker, Christie

AU - Oteng-Ntim, Eugene

AU - Guggilla, Rama

AU - Gupta, Manish

AU - Patwardhan, Manasi

AU - Mataya, Ronald

AU - Mallett Moore, Tamala

AU - Alguacil-Ramos, Ana Maria

AU - Keech, Cheryl

AU - Gravett, Michael

AU - Murphy, Helen

AU - Kochhar, Sonali

AU - Chescheir, Nancy

N1 - Funding Information: The authors are grateful for the support and helpful comments provided by the Brighton Collaboration and the reference group (see https://brightoncollaboration.org/public/what-we-do/setting-standards/case-definitions/groups.html for reviewers), as well as other experts consulted as part of the process. These experts include Dr. Alastair McKelvey, Subspecialist in Maternal-Fetal Medicine and Associate Professor in Obstetrics and Gynaecology at the Norfolk and Norwich University Hospitals NHS Foundation Trust, UK, as well as Lara Handler, Medicine Librarian, UNC Health Sciences Library, Monica Weiss-Nolen, Information Scientist at Sanofi Pasteur, USA, and Sonja Banga, at Sanofi Pasteur, Canada. The authors are also grateful to Jan Bonhoeffer, Jorgen Bauwens of the Brighton Collaboration Secretariat and Sonali Kochhar of Global Healthcare Consulting for final revisions of the final document. Finally, we would like to acknowledge the Global Alignment of Immunization Safety Assessment in Pregnancy (GAIA) project, funded by the Bill and Melinda Gates Foundation.

PY - 2017/12/4

Y1 - 2017/12/4

UR - http://www.scopus.com/inward/record.url?scp=85034025897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034025897&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2017.01.043

DO - 10.1016/j.vaccine.2017.01.043

M3 - Comment/debate

C2 - 29150061

SN - 0264-410X

VL - 35

SP - 6555

EP - 6562

JO - Vaccine

JF - Vaccine

IS - 48

ER -

Gestational diabetes mellitus: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data

ASJC Scopus Subject Areas

Access to Document

OpenUrl availability

Other files and links

Cite this